You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Effect of CD4+ T cell count on treatment-emergent adverse events among patients with and without HIV receiving immunotherapy for advanced cancer

 

Online download statistics by month:

Online download statistics by month: September 2022 to February 2026

AbstractFullPdf
Sep 202255557495
Oct 202217217836
Nov 2022808630
Dec 2022828420
Jan 2023767613
Feb 2023818215
Mar 2023585820
Apr 2023464712
May 2023404014
Jun 202329296
Jul 2023313219
Aug 202327275
Sep 202317173
Oct 202336388
Nov 2023929425
Dec 2023717122
Jan 2024666922
Feb 202441041215
Mar 202431531588
Apr 2024777834
May 202426626832
Jun 2024858426
Jul 2024919327
Aug 2024646325
Sep 2024616131
Oct 2024323228
Nov 2024525330
Dec 202410510929
Jan 2025424222
Feb 2025464629
Mar 2025232325
Apr 2025454515
May 2025252519
Jun 2025191912
Jul 2025110
Sep 2025110
Dec 2025110
Feb 2026110
Total33213374852